MoonLake Immunotherapeutics
About:
MoonLake Immunotherapeutics is a clinical-stage biopharmaceuticals company.
Website: https://moonlaketx.com/
Top Investors: Cormorant Asset Management, Biotechnology Value Fund, RTW Investments, Surveyor Capital, Monashee Investment Management
Description:
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company crating novel therapies, and unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients.
Total Funding Amount:
$515M
Headquarters Location:
Zug, Zug, Switzerland
Founded Date:
2021-03-01
Contact Email:
info(AT)moonlaketx.comc
Founders:
Number of Employees:
11-50
Last Funding Date:
2023-06-28
IPO Status:
Public
Industries:
© 2025 bioDAO.ai